Bibliographic Details
| Title: |
High-Affinity DARPin Allows Targeting of MeV to Glioblastoma Multiforme in Combination with Protease Targeting without Loss of Potency |
| Authors: |
Jan R.H. Hanauer, Vivian Koch, Ulrich M. Lauer, Michael D. Mühlebach |
| Source: |
Molecular Therapy: Oncolytics, Vol 15, Iss , Pp 186-200 (2019) |
| Publisher Information: |
Elsevier, 2019. |
| Publication Year: |
2019 |
| Collection: |
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| Subject Terms: |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| More Details: |
Measles virus (MeV) is naturally cytolytic by extensive cell-to-cell fusion. Vaccine-derived MeV is toxic for cancer cells and is clinically tested as oncolytic virus. To combine the potential of MeV with enhanced safety, different targeting strategies have been described. We generated a receptor-targeted MeV by using receptor-blind viral attachment protein genetically fused to designed ankyrin repeat protein (DARPin) binding domains specific for the epidermal growth factor receptor (EGFR). To reduce on-target toxicity for EGFR+ healthy cells, we used an engineered viral fusion protein activatable by tumor-associated matrix metalloproteases (MMPs) for additional protease targeting. The dual-targeted virus replicated exclusively on EGFR+/MMP+ tumor cells but was safe on healthy EGFR+ target cells, primary human keratinocytes. Nevertheless, glioblastoma and other tumor cells were efficiently killed by all targeted viruses, although replication and oncolysis were slower for protease-targeted MeV. In vivo, efficacy of EGFR-targeted MeV was virtually unimpaired, whereas also dual-targeted MeV showed significant intra-tumoral spread and efficacy and could be armed with a prodrug convertase. The use of DARPin-domains resulted in potent EGFR-targeted MeV and for the first time effective dual retargeting of an oncolytic virus, further enhancing tumor selectivity. Together with powerful cell-toxic genes, the application as highly tumor-specific platform is promising. Keywords: measles virus, virotherapy, entry targeting, receptor targeting, protease targeting, oncolytic viruses, glioblastoma multiforme |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
2372-7705 |
| Relation: |
http://www.sciencedirect.com/science/article/pii/S2372770519300944; https://doaj.org/toc/2372-7705 |
| DOI: |
10.1016/j.omto.2019.10.004 |
| Access URL: |
https://doaj.org/article/8c68c3450c474b758f4a914f0657803a |
| Accession Number: |
edsdoj.8c68c3450c474b758f4a914f0657803a |
| Database: |
Directory of Open Access Journals |
